Skip to Content

BioPharma Strategy Blog

Pharma Early Stage New Product Forecasting Efforts - It's the Journey, Not the Destination That's Important

Early stage pharma forecasting can be a valuable exercise helping to drive clinical development and commercialization efforts, or end up as a “check the box” activity given merely an afterthought in strategic planning efforts. The difference is all in the approach. Early forecast numbers may be of little strategic value when projections are made without factoring market environmental trends and consumer behavioral tendencies. 

50% Discounts on Pharma, Biotech, and Healthcare Market Reports for the Month of October

Now Offering 50% Discounts on Business Insights Limited* Pharma, Biotech and Healthcare Market Reports and $250 For Single Data Point Queries throughout the month of October.  Learn More.
 
When exploring new markets and seeking topline updates on recent market trends, syndicated market reports are a great place to get started for an orientation and a Telescope view. 

Why Your Opinion Although Interesting, Is Irrelevant When it Comes to Commercializing New Drugs

I recently came across a book entitled, Tuned In – Uncover the Extraordinary Opportunities That Lead to Business Breakthroughs, by Craig Stull, Phil Myers & David Meerman Scott. The authors talk about a Tuned In process for developing new products that resonate with target customers. As part of the process, they have a saying that they repeat multiple times throughout the book, &

Welcome to Pharmacision and Rapid Insights

Thanks for reading and I hope the Biopharma Strategy Blog provides ideas and some new insights as you evaluate business development and licensing opportunities or develop commercialization strategies for your lead compounds or biologicals in development.  If you have any suggestions or ideas for future articles or blog topics, please send me an email at tmarten@pharmacision.com.

Syndicate content